SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-007242
Filing Date
2011-02-03
Accepted
2011-02-03 19:12:47
Documents
1
Period of Report
2011-02-02

Document Format Files

Seq Description Document Type Size
1 2011 ANNUAL GRANT rrd299683.html 4  
1 2011 ANNUAL GRANT rrd299683.xml 4 4586
  Complete submission text file 0001181431-11-007242.txt   6523
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCEPT PHARMACEUTICALS INC 1003 W CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address
Moore Terrence O (Reporting) CIK: 0001454276 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 11572134